C54.9
Malignant neoplasm of corpus uteri, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the corpus uteri, commonly known as uterine cancer, is a type of cancer that originates in the body of the uterus, also called the corpus. The corpus is the main part of the uterus, a vital reproductive organ in women. When the cancer is unspecified under ICD-10 code C54.9, it indicates that the specific location or type within the corpus is not detailed. This condition primarily affects women and can have serious health implications if not diagnosed and treated early. Understanding the risk factors, symptoms, and available treatment options can help in managing this disease effectively.
Causes & Symptoms
Clinical Causes: Hormonal imbalance, especially prolonged exposure to estrogen without progesterone balance Obesity, which increases estrogen levels Age-related changes, mainly affecting women over 50 History of reproductive issues, such as late menopause or never having given birth Genetic factors and family history of uterine or other related cancers History of radiation therapy in the pelvic area Certain inherited conditions like Lynch syndrome Use of tamoxifen for breast cancer treatment
Key Symptoms: Abnormal uterine bleeding, especially bleeding between periods or after menopause Pelvic pain or pressure Unusual vaginal discharge Pain during intercourse Difficulty urinating or bowel movements in advanced cases Unexplained weight loss or fatigue in later stages
Diagnostic & Treatment
Diagnosis Path: Diagnosing uterine cancer involves a combination of medical evaluation and diagnostic tests. Initially, a healthcare provider will review the patient's medical history and conduct a physical examination, focusing on the pelvic area. Common diagnostic procedures include: - **Pelvic Ultrasound:** Helps visualize the uterus and detect abnormalities. - **Endometrial Biopsy:** The removal of a small tissue sample from the lining of the uterus for laboratory analysis. - **Dilitation and Curettage (D&C):** A procedure to scrape tissue from the uterus for biopsy. - **Hysteroscopy:** Using a thin camera inserted into the uterus to examine the lining directly. - **Imaging Tests:** Such as MRI or CT scans to assess the spread or extent of disease.
Treatment Protocols: Treatment strategies for uterine cancer depend on the stage and specific characteristics of the tumor. Common options include: - **Surgical Intervention:** The primary treatment often involves hysterectomy, which is the removal of the uterus. Omentectomy and lymph node removal may also be performed. - **Radiation Therapy:** High-energy radiation to destroy cancer cells, used alone or alongside surgery. - **Hormone Therapy:** Using hormonal agents like progestins to slow or stop cancer growth in certain cases. - **Chemotherapy:** The use of drugs to kill cancer cells, especially if the disease has spread. - **Targeted Therapy:** Medications that specifically target cancer cells’ unique proteins or genetic mutations. - **Follow-up and Monitoring:** Regular check-ups to detect any recurrence or complications early.
Clinical Advice & FAQs
Billing Guidance
Is C54.9 a billable ICD-10 code?
Yes, C54.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C54.9?
Clinical documentation must specify the nature of Malignant neoplasm of corpus uteri, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference